As of June 21, 2025, Liberty Health Sciences Inc (LHS.CN) reports a Net Margin of 44.47%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Liberty Health Sciences Inc's Net Margin
Over recent years, Liberty Health Sciences Inc's Net Margin has shown a stable trend. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2020-02-29 | 44.47% |
| 2019-02-28 | -222.88% |
| 2018-02-28 | -4765.73% |
This steady improvement highlights how Liberty Health Sciences Inc manages its overall profitability and cost control over time.
Comparing Liberty Health Sciences Inc's Net Margin to Peers
To better understand Liberty Health Sciences Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Liberty Health Sciences Inc (LHS.CN) | 44.47% |
| AcelRx Pharmaceuticals Inc (ACRX) | 2698.31% |
| Lotus Pharmaceuticals Inc (LTUS) | 19.84% |
| Knight Therapeutics Inc (GUD.TO) | 1.17% |
| High Tide Inc (HITI.V) | -0.83% |
| Harrow Health Inc (HROW) | -8.76% |
Compared to its competitors, Liberty Health Sciences Inc's Net Margin is among the highest compared to peers, suggesting strong overall cost management and pricing power.